img

Global 3D Printing Pharmaceuticals Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global 3D Printing Pharmaceuticals Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
3D Printing Pharmaceuticals report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global 3D Printing Pharmaceuticals market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Personalized Pharmacy and Nutrients are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for 3D Printing Pharmaceuticals industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, 3D Printing Pharmaceuticals key manufacturers include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA and TNO, etc. Triastek,Inc., Aprecia, AstraZeneca are top 3 players and held % sales share in total in 2022.
3D Printing Pharmaceuticals can be divided into FDM, SLS, PB and SLA, etc. FDM is the mainstream product in the market, accounting for % sales share globally in 2022.
3D Printing Pharmaceuticals is widely used in various fields, such as Personalized Pharmacy and Nutrients, etc. Personalized Pharmacy provides greatest supports to the 3D Printing Pharmaceuticals industry development. In 2022, global % sales of 3D Printing Pharmaceuticals went into Personalized Pharmacy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global 3D Printing Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Triastek,Inc.
Aprecia
AstraZeneca
FabRx
Multiply Labs
DiHeSys
Merck
Merck KGaA
TNO
Therics
Segment by Type
FDM
SLS
PB
SLA
SSE
DPE
DOD
MDD
MED

Segment by Application


Personalized Pharmacy
Nutrients

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the 3D Printing Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of 3D Printing Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the 3D Printing Pharmaceuticals industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of 3D Printing Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, 3D Printing Pharmaceuticals introduction, etc. 3D Printing Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of 3D Printing Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 3D Printing Pharmaceuticals Market Overview
1.1 3D Printing Pharmaceuticals Product Overview
1.2 3D Printing Pharmaceuticals Market Segment by Type
1.2.1 FDM
1.2.2 SLS
1.2.3 PB
1.2.4 SLA
1.2.5 SSE
1.2.6 DPE
1.2.7 DOD
1.2.8 MDD
1.2.9 MED
1.3 Global 3D Printing Pharmaceuticals Market Size by Type
1.3.1 Global 3D Printing Pharmaceuticals Market Size Overview by Type (2024-2034)
1.3.2 Global 3D Printing Pharmaceuticals Historic Market Size Review by Type (2024-2024)
1.3.3 Global 3D Printing Pharmaceuticals Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America 3D Printing Pharmaceuticals Sales Breakdown by Type (2024-2024)
1.4.2 Europe 3D Printing Pharmaceuticals Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific 3D Printing Pharmaceuticals Sales Breakdown by Type (2024-2024)
1.4.4 Latin America 3D Printing Pharmaceuticals Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa 3D Printing Pharmaceuticals Sales Breakdown by Type (2024-2024)
2 Global 3D Printing Pharmaceuticals Market Competition by Company
2.1 Global Top Players by 3D Printing Pharmaceuticals Sales (2024-2024)
2.2 Global Top Players by 3D Printing Pharmaceuticals Revenue (2024-2024)
2.3 Global Top Players by 3D Printing Pharmaceuticals Price (2024-2024)
2.4 Global Top Manufacturers 3D Printing Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type
2.5 3D Printing Pharmaceuticals Market Competitive Situation and Trends
2.5.1 3D Printing Pharmaceuticals Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by 3D Printing Pharmaceuticals Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 3D Printing Pharmaceuticals as of 2022)
2.7 Date of Key Manufacturers Enter into 3D Printing Pharmaceuticals Market
2.8 Key Manufacturers 3D Printing Pharmaceuticals Product Offered
2.9 Mergers & Acquisitions, Expansion
3 3D Printing Pharmaceuticals Status and Outlook by Region
3.1 Global 3D Printing Pharmaceuticals Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global 3D Printing Pharmaceuticals Historic Market Size by Region
3.2.1 Global 3D Printing Pharmaceuticals Sales in Volume by Region (2024-2024)
3.2.2 Global 3D Printing Pharmaceuticals Sales in Value by Region (2024-2024)
3.2.3 Global 3D Printing Pharmaceuticals Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global 3D Printing Pharmaceuticals Forecasted Market Size by Region
3.3.1 Global 3D Printing Pharmaceuticals Sales in Volume by Region (2024-2034)
3.3.2 Global 3D Printing Pharmaceuticals Sales in Value by Region (2024-2034)
3.3.3 Global 3D Printing Pharmaceuticals Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global 3D Printing Pharmaceuticals by Application
4.1 3D Printing Pharmaceuticals Market Segment by Application
4.1.1 Personalized Pharmacy
4.1.2 Nutrients
4.2 Global 3D Printing Pharmaceuticals Market Size by Application
4.2.1 Global 3D Printing Pharmaceuticals Market Size Overview by Application (2024-2034)
4.2.2 Global 3D Printing Pharmaceuticals Historic Market Size Review by Application (2024-2024)
4.2.3 Global 3D Printing Pharmaceuticals Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America 3D Printing Pharmaceuticals Sales Breakdown by Application (2024-2024)
4.3.2 Europe 3D Printing Pharmaceuticals Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific 3D Printing Pharmaceuticals Sales Breakdown by Application (2024-2024)
4.3.4 Latin America 3D Printing Pharmaceuticals Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa 3D Printing Pharmaceuticals Sales Breakdown by Application (2024-2024)
5 North America 3D Printing Pharmaceuticals by Country
5.1 North America 3D Printing Pharmaceuticals Historic Market Size by Country
5.1.1 North America 3D Printing Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2024)
5.1.3 North America 3D Printing Pharmaceuticals Sales in Value by Country (2024-2024)
5.2 North America 3D Printing Pharmaceuticals Forecasted Market Size by Country
5.2.1 North America 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2034)
5.2.2 North America 3D Printing Pharmaceuticals Sales in Value by Country (2024-2034)
6 Europe 3D Printing Pharmaceuticals by Country
6.1 Europe 3D Printing Pharmaceuticals Historic Market Size by Country
6.1.1 Europe 3D Printing Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2024)
6.1.3 Europe 3D Printing Pharmaceuticals Sales in Value by Country (2024-2024)
6.2 Europe 3D Printing Pharmaceuticals Forecasted Market Size by Country
6.2.1 Europe 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2034)
6.2.2 Europe 3D Printing Pharmaceuticals Sales in Value by Country (2024-2034)
7 Asia-Pacific 3D Printing Pharmaceuticals by Region
7.1 Asia-Pacific 3D Printing Pharmaceuticals Historic Market Size by Region
7.1.1 Asia-Pacific 3D Printing Pharmaceuticals Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific 3D Printing Pharmaceuticals Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific 3D Printing Pharmaceuticals Sales in Value by Region (2024-2024)
7.2 Asia-Pacific 3D Printing Pharmaceuticals Forecasted Market Size by Region
7.2.1 Asia-Pacific 3D Printing Pharmaceuticals Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific 3D Printing Pharmaceuticals Sales in Value by Region (2024-2034)
8 Latin America 3D Printing Pharmaceuticals by Country
8.1 Latin America 3D Printing Pharmaceuticals Historic Market Size by Country
8.1.1 Latin America 3D Printing Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2024)
8.1.3 Latin America 3D Printing Pharmaceuticals Sales in Value by Country (2024-2024)
8.2 Latin America 3D Printing Pharmaceuticals Forecasted Market Size by Country
8.2.1 Latin America 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2034)
8.2.2 Latin America 3D Printing Pharmaceuticals Sales in Value by Country (2024-2034)
9 Middle East and Africa 3D Printing Pharmaceuticals by Country
9.1 Middle East and Africa 3D Printing Pharmaceuticals Historic Market Size by Country
9.1.1 Middle East and Africa 3D Printing Pharmaceuticals Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa 3D Printing Pharmaceuticals Sales in Value by Country (2024-2024)
9.2 Middle East and Africa 3D Printing Pharmaceuticals Forecasted Market Size by Country
9.2.1 Middle East and Africa 3D Printing Pharmaceuticals Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa 3D Printing Pharmaceuticals Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Triastek,Inc.
10.1.1 Triastek,Inc. Company Information
10.1.2 Triastek,Inc. Introduction and Business Overview
10.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Products Offered
10.1.5 Triastek,Inc. Recent Development
10.2 Aprecia
10.2.1 Aprecia Company Information
10.2.2 Aprecia Introduction and Business Overview
10.2.3 Aprecia 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Aprecia 3D Printing Pharmaceuticals Products Offered
10.2.5 Aprecia Recent Development
10.3 AstraZeneca
10.3.1 AstraZeneca Company Information
10.3.2 AstraZeneca Introduction and Business Overview
10.3.3 AstraZeneca 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.3.4 AstraZeneca 3D Printing Pharmaceuticals Products Offered
10.3.5 AstraZeneca Recent Development
10.4 FabRx
10.4.1 FabRx Company Information
10.4.2 FabRx Introduction and Business Overview
10.4.3 FabRx 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.4.4 FabRx 3D Printing Pharmaceuticals Products Offered
10.4.5 FabRx Recent Development
10.5 Multiply Labs
10.5.1 Multiply Labs Company Information
10.5.2 Multiply Labs Introduction and Business Overview
10.5.3 Multiply Labs 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Multiply Labs 3D Printing Pharmaceuticals Products Offered
10.5.5 Multiply Labs Recent Development
10.6 DiHeSys
10.6.1 DiHeSys Company Information
10.6.2 DiHeSys Introduction and Business Overview
10.6.3 DiHeSys 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.6.4 DiHeSys 3D Printing Pharmaceuticals Products Offered
10.6.5 DiHeSys Recent Development
10.7 Merck
10.7.1 Merck Company Information
10.7.2 Merck Introduction and Business Overview
10.7.3 Merck 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Merck 3D Printing Pharmaceuticals Products Offered
10.7.5 Merck Recent Development
10.8 Merck KGaA
10.8.1 Merck KGaA Company Information
10.8.2 Merck KGaA Introduction and Business Overview
10.8.3 Merck KGaA 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Merck KGaA 3D Printing Pharmaceuticals Products Offered
10.8.5 Merck KGaA Recent Development
10.9 TNO
10.9.1 TNO Company Information
10.9.2 TNO Introduction and Business Overview
10.9.3 TNO 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.9.4 TNO 3D Printing Pharmaceuticals Products Offered
10.9.5 TNO Recent Development
10.10 Therics
10.10.1 Therics Company Information
10.10.2 Therics Introduction and Business Overview
10.10.3 Therics 3D Printing Pharmaceuticals Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Therics 3D Printing Pharmaceuticals Products Offered
10.10.5 Therics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 3D Printing Pharmaceuticals Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 3D Printing Pharmaceuticals Industrial Chain Analysis
11.4 3D Printing Pharmaceuticals Market Dynamics
11.4.1 3D Printing Pharmaceuticals Industry Trends
11.4.2 3D Printing Pharmaceuticals Market Drivers
11.4.3 3D Printing Pharmaceuticals Market Challenges
11.4.4 3D Printing Pharmaceuticals Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 3D Printing Pharmaceuticals Distributors
12.3 3D Printing Pharmaceuticals Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of FDM
Table 2. Major Company of SLS
Table 3. Major Company of PB
Table 4. Major Company of SLA
Table 5. Major Company of SSE
Table 6. Major Company of DPE
Table 7. Major Company of DOD
Table 8. Major Company of MDD
Table 9. Major Company of MED
Table 10. Global 3D Printing Pharmaceuticals Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 11. Global 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (K Units)
Table 12. Global 3D Printing Pharmaceuticals Sales Market Share in Volume by Type (2024-2024)
Table 13. Global 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (US& Million)
Table 14. Global 3D Printing Pharmaceuticals Market Share in Value by Type (2024-2024)
Table 15. Global 3D Printing Pharmaceuticals Price by Type (2024-2024) & (US$/Unit)
Table 16. Global 3D Printing Pharmaceuticals Sales by Type (2024-2034) & (K Units)
Table 17. Global 3D Printing Pharmaceuticals Sales Market Share in Volume by Type (2024-2034)
Table 18. Global 3D Printing Pharmaceuticals Sales by Type (2024-2034) & (US$ Million)
Table 19. Global 3D Printing Pharmaceuticals Sales Market Share in Value by Type (2024-2034)
Table 20. Global 3D Printing Pharmaceuticals Price by Type (2024-2034) & (US$/Unit)
Table 21. North America 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (K Units)
Table 22. North America 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (US$ Million)
Table 23. Europe 3D Printing Pharmaceuticals Sales (K Units) by Type (2024-2024)
Table 24. Europe 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (US$ Million)
Table 25. Asia-Pacific 3D Printing Pharmaceuticals Sales (K Units) by Type (2024-2024)
Table 26. Asia-Pacific 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (US$ Million)
Table 27. Latin America 3D Printing Pharmaceuticals Sales (K Units) by Type (2024-2024)
Table 28. Latin America 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (US$ Million)
Table 29. Middle East and Africa 3D Printing Pharmaceuticals Sales (K Units) by Type (2024-2024)
Table 30. Middle East and Africa 3D Printing Pharmaceuticals Sales by Type (2024-2024) & (US$ Million)
Table 31. Global 3D Printing Pharmaceuticals Sales by Company (2024-2024) & (K Units)
Table 32. Global 3D Printing Pharmaceuticals Sales Share by Company (2024-2024)
Table 33. Global 3D Printing Pharmaceuticals Revenue by Company (2024-2024) & (US$ Million)
Table 34. Global 3D Printing Pharmaceuticals Revenue Share by Company (2024-2024)
Table 35. Global Market 3D Printing Pharmaceuticals Price by Company (2024-2024) & (US$/Unit)
Table 36. Global 3D Printing Pharmaceuticals Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 37. Global 3D Printing Pharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 38. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in 3D Printing Pharmaceuticals as of 2022)
Table 39. Date of Key Manufacturers Enter into 3D Printing Pharmaceuticals Market
Table 40. Key Manufacturers 3D Printing Pharmaceuticals Product Type
Table 41. Mergers & Acquisitions, Expansion Plans
Table 42. Global 3D Printing Pharmaceuticals Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 43. Global 3D Printing Pharmaceuticals Sales by Region (2024-2024) & (K Units)
Table 44. Global 3D Printing Pharmaceuticals Sales Market Share in Volume by Region (2024-2024)
Table 45. Global 3D Printing Pharmaceuticals Sales by Region (2024-2024) & (US$ Million)
Table 46. Global 3D Printing Pharmaceuticals Sales Market Share in Value by Region (2024-2024)
Table 47. Global 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 48. Global 3D Printing Pharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 49. Global 3D Printing Pharmaceuticals Sales Market Share in Volume by Region (2024-2034)
Table 50. Global 3D Printing Pharmaceuticals Sales by Region (2024-2034) & (US$ Million)
Table 51. Global 3D Printing Pharmaceuticals Sales Market Share in Value by Region (2024-2034)
Table 52. Global 3D Printing Pharmaceuticals Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 53. Global 3D Printing Pharmaceuticals Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 54. Global 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (K Units)
Table 55. Global 3D Printing Pharmaceuticals Sales Market Share in Volume by Application (2024-2024)
Table 56. Global 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (US$ Million)
Table 57. Global 3D Printing Pharmaceuticals Sales Market Share in Value by Application (2024-2024)
Table 58. Global 3D Printing Pharmaceuticals Price by Application (2024-2024) & (US$/Unit)
Table 59. Global 3D Printing Pharmaceuticals Sales by Application (2024-2034) & (K Units)
Table 60. Global 3D Printing Pharmaceuticals Sales Market Share in Volume by Application (2024-2034)
Table 61. Global 3D Printing Pharmaceuticals Sales by Application (2024-2034) & (US$ Million)
Table 62. Global 3D Printing Pharmaceuticals Sales Market Share in Value by Application (2024-2034)
Table 63. Global 3D Printing Pharmaceuticals Price by Application (2024-2034) & (US$/Unit)
Table 64. North America 3D Printing Pharmaceuticals Sales by Application (2024-2024) (K Units)
Table 65. North America 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (US$ Million)
Table 66. Europe 3D Printing Pharmaceuticals Sales by Application (2024-2024) (K Units)
Table 67. Europe 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (US$ Million)
Table 68. Asia-Pacific 3D Printing Pharmaceuticals Sales by Application (2024-2024) (K Units)
Table 69. Asia-Pacific 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (US$ Million)
Table 70. Latin America 3D Printing Pharmaceuticals Sales by Application (2024-2024) (K Units)
Table 71. Latin America 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (US$ Million)
Table 72. Middle East and Africa 3D Printing Pharmaceuticals Sales by Application (2024-2024) (K Units)
Table 73. Middle East and Africa 3D Printing Pharmaceuticals Sales by Application (2024-2024) & (US$ Million)
Table 74. North America 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (K Units)
Table 75. North America 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2024)
Table 76. North America 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (US$ Million)
Table 77. North America 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2024)
Table 78. North America 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 79. North America 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 80. North America 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 81. North America 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 82. Europe 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (K Units)
Table 83. Europe 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2024)
Table 84. Europe 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (US$ Million)
Table 85. Europe 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2024)
Table 86. Europe 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 87. Europe 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 88. Europe 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 89. Europe 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 90. Asia-Pacific 3D Printing Pharmaceuticals Sales by Region (2024-2024) & (K Units)
Table 91. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Volume by Region (2024-2024)
Table 92. Asia-Pacific 3D Printing Pharmaceuticals Sales by Region (2024-2024) & (US$ Million)
Table 93. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Value by Region (2024-2024)
Table 94. Asia-Pacific 3D Printing Pharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 95. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Volume by Region (2024-2034)
Table 96. Asia-Pacific 3D Printing Pharmaceuticals Sales by Region (2024-2034) & (US$ Million)
Table 97. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Value by Region (2024-2034)
Table 98. Latin America 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (K Units)
Table 99. Latin America 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2024)
Table 100. Latin America 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (US$ Million)
Table 101. Latin America 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2024)
Table 102. Latin America 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 103. Latin America 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 104. Latin America 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 105. Latin America 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 106. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (K Units)
Table 107. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2024)
Table 108. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2024-2024) & (US$ Million)
Table 109. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2024)
Table 110. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 111. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Volume by Country (2024-2034)
Table 112. Middle East and Africa 3D Printing Pharmaceuticals Sales by Country (2024-2034) & (US$ Million)
Table 113. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Value by Country (2024-2034)
Table 114. Triastek,Inc. Company Information
Table 115. Triastek,Inc. Introduction and Business Overview
Table 116. Triastek,Inc. 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 117. Triastek,Inc. 3D Printing Pharmaceuticals Product
Table 118. Triastek,Inc. Recent Development
Table 119. Aprecia Company Information
Table 120. Aprecia Introduction and Business Overview
Table 121. Aprecia 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 122. Aprecia 3D Printing Pharmaceuticals Product
Table 123. Aprecia Recent Development
Table 124. AstraZeneca Company Information
Table 125. AstraZeneca Introduction and Business Overview
Table 126. AstraZeneca 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 127. AstraZeneca 3D Printing Pharmaceuticals Product
Table 128. AstraZeneca Recent Development
Table 129. FabRx Company Information
Table 130. FabRx Introduction and Business Overview
Table 131. FabRx 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 132. FabRx 3D Printing Pharmaceuticals Product
Table 133. FabRx Recent Development
Table 134. Multiply Labs Company Information
Table 135. Multiply Labs Introduction and Business Overview
Table 136. Multiply Labs 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 137. Multiply Labs 3D Printing Pharmaceuticals Product
Table 138. Multiply Labs Recent Development
Table 139. DiHeSys Company Information
Table 140. DiHeSys Introduction and Business Overview
Table 141. DiHeSys 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 142. DiHeSys 3D Printing Pharmaceuticals Product
Table 143. DiHeSys Recent Development
Table 144. Merck Company Information
Table 145. Merck Introduction and Business Overview
Table 146. Merck 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 147. Merck 3D Printing Pharmaceuticals Product
Table 148. Merck Recent Development
Table 149. Merck KGaA Company Information
Table 150. Merck KGaA Introduction and Business Overview
Table 151. Merck KGaA 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 152. Merck KGaA 3D Printing Pharmaceuticals Product
Table 153. Merck KGaA Recent Development
Table 154. TNO Company Information
Table 155. TNO Introduction and Business Overview
Table 156. TNO 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 157. TNO 3D Printing Pharmaceuticals Product
Table 158. TNO Recent Development
Table 159. Therics Company Information
Table 160. Therics Introduction and Business Overview
Table 161. Therics 3D Printing Pharmaceuticals Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 162. Therics 3D Printing Pharmaceuticals Product
Table 163. Therics Recent Development
Table 164. Key Raw Materials Lists
Table 165. Raw Materials Key Suppliers Lists
Table 166. 3D Printing Pharmaceuticals Market Trends
Table 167. 3D Printing Pharmaceuticals Market Drivers
Table 168. 3D Printing Pharmaceuticals Market Challenges
Table 169. 3D Printing Pharmaceuticals Market Restraints
Table 170. 3D Printing Pharmaceuticals Distributors List
Table 171. 3D Printing Pharmaceuticals Downstream Customers
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. 3D Printing Pharmaceuticals Product Picture
Figure 2. Global 3D Printing Pharmaceuticals Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global 3D Printing Pharmaceuticals Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global 3D Printing Pharmaceuticals Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of FDM
Figure 6. Global FDM Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of SLS
Figure 8. Global SLS Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of PB
Figure 10. Global PB Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of SLA
Figure 12. Global SLA Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of SSE
Figure 14. Global SSE Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of DPE
Figure 16. Global DPE Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Product Picture of DOD
Figure 18. Global DOD Sales YoY Growth (2024-2034) & (K Units)
Figure 19. Product Picture of MDD
Figure 20. Global MDD Sales YoY Growth (2024-2034) & (K Units)
Figure 21. Product Picture of MED
Figure 22. Global MED Sales YoY Growth (2024-2034) & (K Units)
Figure 23. Global 3D Printing Pharmaceuticals Sales by Type (2024-2034) & (US$ Million)
Figure 24. Global 3D Printing Pharmaceuticals Sales Market Share by Type in 2022 & 2034
Figure 25. North America 3D Printing Pharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 26. North America 3D Printing Pharmaceuticals Sales Market Share in Value by Type in 2022
Figure 27. Europe 3D Printing Pharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 28. Europe 3D Printing Pharmaceuticals Sales Market Share in Value by Type in 2022
Figure 29. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 30. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Value by Type in 2022
Figure 31. Latin America 3D Printing Pharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 32. Latin America 3D Printing Pharmaceuticals Sales Market Share in Value by Type in 2022
Figure 33. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Volume by Type in 2022
Figure 34. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Value by Type in 2022
Figure 35. The 5 and 10 Largest Manufacturers in the World: Market Share by 3D Printing Pharmaceuticals Sales in 2022
Figure 36. The 5 and 10 Largest Manufacturers in the World: Market Share by 3D Printing Pharmaceuticals Revenue in 2022
Figure 37. 3D Printing Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 38. Product Picture of Personalized Pharmacy
Figure 39. Global Personalized Pharmacy Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Nutrients
Figure 41. Global Nutrients Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Global 3D Printing Pharmaceuticals Sales by Application (2024-2034) & (US$ Million)
Figure 43. Global 3D Printing Pharmaceuticals Sales Market Share by Application in 2022 & 2034
Figure 44. North America 3D Printing Pharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 45. North America 3D Printing Pharmaceuticals Sales Market Share in Value by Application in 2022
Figure 46. Europe 3D Printing Pharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 47. Europe 3D Printing Pharmaceuticals Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific 3D Printing Pharmaceuticals Sales Market Share in Value by Application in 2022
Figure 50. Latin America 3D Printing Pharmaceuticals Sales Market Share in Volume by Application in 2022
Figure 51. Latin America 3D Printing Pharmaceuticals Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa 3D Printing Pharmaceuticals Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. 3D Printing Pharmaceuticals Manufacturing Cost Structure
Figure 55. 3D Printing Pharmaceuticals Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed